Clinical Trial Update: A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers [Phase 2]

View source ↗

Summary

Phase II randomized trial assessing immunotherapy plus radiotherapy in metastatic genitourinary cancers; study terminated with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Urothelial Carcinoma

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Metastatic Renal Cell Carcinoma, Metastatic Urothelial Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2021-09-22